ID   ABHD5_RAT               Reviewed;         351 AA.
AC   Q6QA69;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   29-MAY-2024, entry version 137.
DE   RecName: Full=1-acylglycerol-3-phosphate O-acyltransferase ABHD5 {ECO:0000305};
DE            EC=2.3.1.51 {ECO:0000250|UniProtKB:Q8WTS1};
DE   AltName: Full=Abhydrolase domain-containing protein 5;
DE   AltName: Full=Lipid droplet-binding protein CGI-58;
DE            Short=Protein CGI-58;
GN   Name=Abhd5 {ECO:0000312|RGD:1303237};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH PLIN AND ADRP, SUBCELLULAR
RP   LOCATION, INDUCTION, AND MUTAGENESIS OF GLU-9; GLN-132 AND GLU-262.
RX   PubMed=15136565; DOI=10.1074/jbc.m403920200;
RA   Yamaguchi T., Omatsu N., Matsushita S., Osumi T.;
RT   "CGI-58 interacts with perilipin and is localized to lipid droplets.
RT   Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman
RT   syndrome.";
RL   J. Biol. Chem. 279:30490-30497(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [3]
RP   INTERACTION WITH PLIN5.
RX   PubMed=23408028; DOI=10.1152/ajpregu.00418.2012;
RA   MacPherson R.E., Ramos S.V., Vandenboom R., Roy B.D., Peters S.J.;
RT   "Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and
RT   following stimulated contraction.";
RL   Am. J. Physiol. 304:R644-R650(2013).
CC   -!- FUNCTION: Coenzyme A-dependent lysophosphatidic acid acyltransferase
CC       that catalyzes the transfer of an acyl group on a lysophosphatidic
CC       acid. Functions preferentially with 1-oleoyl-lysophosphatidic acid
CC       followed by 1-palmitoyl-lysophosphatidic acid, 1-stearoyl-
CC       lysophosphatidic acid and 1-arachidonoyl-lysophosphatidic acid as lipid
CC       acceptor. Functions preferentially with arachidonoyl-CoA followed by
CC       oleoyl-CoA as acyl group donors (By similarity). Functions in
CC       phosphatidic acid biosynthesis (By similarity). May regulate the
CC       cellular storage of triacylglycerol through activation of the
CC       phospholipase PNPLA2 (By similarity). Involved in keratinocyte
CC       differentiation (By similarity). Regulates lipid droplet fusion (By
CC       similarity). {ECO:0000250|UniProtKB:Q8WTS1,
CC       ECO:0000250|UniProtKB:Q9DBL9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphate + an acyl-CoA = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:19709,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57970, ChEBI:CHEBI:58342,
CC         ChEBI:CHEBI:58608; EC=2.3.1.51;
CC         Evidence={ECO:0000250|UniProtKB:Q8WTS1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19710;
CC         Evidence={ECO:0000250|UniProtKB:Q8WTS1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(9Z-octadecenoyl)-sn-glycero-3-
CC         phosphate = 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37131, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74546;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37132;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + hexadecanoyl-CoA
CC         = 1-(9Z)-octadecenoyl-2-hexadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37143, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74551;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37144;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + octadecanoyl-CoA
CC         = 1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37147, ChEBI:CHEBI:57287, ChEBI:CHEBI:57394,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74552;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37148;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoyl-CoA + 1-(9Z-octadecenoyl)-sn-
CC         glycero-3-phosphate = 1-(9Z)-octadecenoyl-2-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37443,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57368, ChEBI:CHEBI:74544,
CC         ChEBI:CHEBI:74928; Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37444;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + eicosanoyl-CoA =
CC         1-(9Z)-octadecenoyl-2-eicosanoyl-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37451, ChEBI:CHEBI:57287, ChEBI:CHEBI:57380,
CC         ChEBI:CHEBI:74544, ChEBI:CHEBI:74937;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37452;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-hexadecanoyl-sn-glycero-3-phosphate
CC         = 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:33187, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:57518, ChEBI:CHEBI:64839;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33188;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-octadecanoyl-sn-glycero-3-phosphate
CC         = 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphate + CoA;
CC         Xref=Rhea:RHEA:37163, ChEBI:CHEBI:57287, ChEBI:CHEBI:57387,
CC         ChEBI:CHEBI:74560, ChEBI:CHEBI:74565;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37164;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycero-3-phosphate = 1-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-2-(9Z)-
CC         octadecenoyl-sn-glycero-3-phosphate + CoA; Xref=Rhea:RHEA:37455,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:74938,
CC         ChEBI:CHEBI:74941; Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37456;
CC         Evidence={ECO:0000250|UniProtKB:Q9DBL9};
CC   -!- ACTIVITY REGULATION: Acyltransferase activity is inhibited by
CC       detergents such as Triton X-100 and 3-[(3-
CC       cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS).
CC       Acyltransferase activity is inhibited by the presence of magnesium and
CC       calcium. {ECO:0000250|UniProtKB:Q9DBL9}.
CC   -!- SUBUNIT: Interacts with ADRP and PLIN. Interacts with PNPLA2 (By
CC       similarity). Interacts with PLIN5; promotes interaction with PNPLA2.
CC       {ECO:0000250, ECO:0000269|PubMed:15136565,
CC       ECO:0000269|PubMed:23408028}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15136565}. Lipid
CC       droplet {ECO:0000269|PubMed:15136565}. Note=Colocalized with PLIN and
CC       ADRP on the surface of lipid droplets. The localization is dependent
CC       upon the metabolic status of the adipocytes and the activity of PKA.
CC   -!- INDUCTION: Increased in the early stage of adipocyte differentiation.
CC       {ECO:0000269|PubMed:15136565}.
CC   -!- DOMAIN: The HXXXXD motif is essential for acyltransferase activity and
CC       may constitute the binding site for the phosphate moiety of the
CC       glycerol-3-phosphate.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family. ABHD4/ABHD5 subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY550934; AAS57860.1; -; mRNA.
DR   RefSeq; NP_997689.1; NM_212524.1.
DR   AlphaFoldDB; Q6QA69; -.
DR   SMR; Q6QA69; -.
DR   STRING; 10116.ENSRNOP00000000239; -.
DR   ESTHER; ratno-abhd5; CGI-58_ABHD5_ABHD4.
DR   MEROPS; S33.975; -.
DR   iPTMnet; Q6QA69; -.
DR   PhosphoSitePlus; Q6QA69; -.
DR   jPOST; Q6QA69; -.
DR   PaxDb; 10116-ENSRNOP00000000239; -.
DR   Ensembl; ENSRNOT00055003514; ENSRNOP00055002620; ENSRNOG00055002210.
DR   Ensembl; ENSRNOT00060030757; ENSRNOP00060024905; ENSRNOG00060017885.
DR   Ensembl; ENSRNOT00065000815; ENSRNOP00065000652; ENSRNOG00065000577.
DR   GeneID; 316122; -.
DR   KEGG; rno:316122; -.
DR   UCSC; RGD:1303237; rat.
DR   AGR; RGD:1303237; -.
DR   CTD; 51099; -.
DR   RGD; 1303237; Abhd5.
DR   VEuPathDB; HostDB:ENSRNOG00000000221; -.
DR   eggNOG; KOG4409; Eukaryota.
DR   HOGENOM; CLU_017361_0_0_1; -.
DR   InParanoid; Q6QA69; -.
DR   OrthoDB; 276964at2759; -.
DR   TreeFam; TF314196; -.
DR   PRO; PR:Q6QA69; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000000221; Expressed in esophagus and 18 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; IDA:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0003841; F:1-acylglycerol-3-phosphate O-acyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0060229; F:lipase activator activity; ISO:RGD.
DR   GO; GO:0042171; F:lysophosphatidic acid acyltransferase activity; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006631; P:fatty acid metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0055088; P:lipid homeostasis; IBA:GO_Central.
DR   GO; GO:0006629; P:lipid metabolic process; IDA:MGI.
DR   GO; GO:0010891; P:negative regulation of sequestering of triglyceride; ISS:UniProtKB.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0050996; P:positive regulation of lipid catabolic process; ISO:RGD.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000073; AB_hydrolase_1.
DR   PANTHER; PTHR42886:SF34; 1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE ABHD5; 1.
DR   PANTHER; PTHR42886; RE40534P-RELATED; 1.
DR   Pfam; PF00561; Abhydrolase_1; 1.
DR   PRINTS; PR00111; ABHYDROLASE.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Cytoplasm; Differentiation; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid droplet; Lipid metabolism;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Phosphoprotein;
KW   Reference proteome; Transferase.
FT   CHAIN           1..351
FT                   /note="1-acylglycerol-3-phosphate O-acyltransferase ABHD5"
FT                   /id="PRO_0000080870"
FT   DOMAIN          79..184
FT                   /note="AB hydrolase-1"
FT                   /evidence="ECO:0000255"
FT   MOTIF           329..334
FT                   /note="HXXXXD motif"
FT   MOD_RES         124
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         9
FT                   /note="E->K: Colocalized to the lipid droplets with PLIN
FT                   and ADPR."
FT                   /evidence="ECO:0000269|PubMed:15136565"
FT   MUTAGEN         132
FT                   /note="Q->P: Exhibits a diffuse cytoplasmic distribution
FT                   without colocalization to lipid droplets with PLIN and
FT                   ADPR. Loss of binding to PLIN."
FT                   /evidence="ECO:0000269|PubMed:15136565"
FT   MUTAGEN         262
FT                   /note="E->K: Exhibits a diffuse cytoplasmic distribution
FT                   without colocalization to lipid droplets with PLIN and
FT                   ADPR. Loss of binding to PLIN."
FT                   /evidence="ECO:0000269|PubMed:15136565"
SQ   SEQUENCE   351 AA;  39104 MW;  DDC5BBA54D8D5ACD CRC64;
     MKAMAAEEEV DSADAGGGSG WLTGWLPTWC PTSTSHLKEA EEKMLKCVPC TYKKEPVRIS
     NGNSIWTLMF SHNMSSKTPL VLLHGFGGGL GLWALNFEDL STDRPVYAFD LLGFGRSSRP
     RFDSDAEEVE NQFVESIEEW RCALRLDKMI LLGHNLGGFL AAAYSLKYPS RVSHLILVEP
     WGFPERPDLA DQERPIPVWI RALGAALTPF NPLAGLRIAG PFGLSLVQRL RPDFKRKYSS
     MFEDDTVTEY IYHCNVQTPS GETAFKNMTI PYGWAKRPML QRIGGLHPDI PVSVIFGARS
     CIDGNSGTSI QSLRPKSYVK TIAILGAGHY VYADQPEEFN QKVKEICHTV D
//
